학술논문

BRAF and MEK inhibitors increase PD-1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti–PD-1 antibody
Document Type
Article
Source
In: Clinical Cancer Research. (Clinical Cancer Research, 15 July 2018, 24(14):3377-3385)
Subject
Language
English
ISSN
15573265
10780432